Home based training using the Xbox Kinect system
BehavioralHome based training 3 times a week for 12 weeks using the Xbox Kinect system
NCT Number: NCT01762241
The purpose of this study is to investigate the effect of 12 weeks systematically training using the Xbox Kinect system.
Outcome measures are made on physical function, quality of life, fatigue and metabolic parameters.
Looking for future studies?
Notify Me40 year and older
Male
Interventional
Not applicable
Urinvejskirurgisk afdeling, Aarhus Universitetshospital, Skejby, Aarhus, Denmark
Patients will be recruited from the outpatient clinic at the urological department, Regionshospitalet Holstebro.
Patients who have been discharged from the outpatient clinic due to biochemical stabile cancer prostate disease will receive a letter with information about the study.
A research assistant will be responsible for randomization and test procedures. A physiotherapist will be responsible for instruction of the participants to the training and the Xbox system.
A student will be responsible for installation and collection of the Xbox system in the participants home.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Home based training 3 times a week for 12 weeks using the Xbox Kinect system
Time frame: Change from baseline to week 12
6 min walk test
Time frame: Change from baseline to week 12
Method: BIoelectrical impedance analysis Bioelectrical impedance
Time frame: Change from baseline to week 12
Leg extensor power
Time frame: Change from baseline to week 12
Fatigue measured using the Functional Assessment of Canter Therapy-Fatigue questionnaire
Time frame: Change from baseline to week 12
Quality of life measured using the Functional Assessment of Canter Therapy-Prostate questionnaire
Time frame: Change from baseline to week 12
Waist circumference (cm)
Time frame: Change from baseline to week 12
Blood pressure (mmHg)
Time frame: Change from baseline to week 12
Body weight (kg)
Time frame: Change from baseline to week 12 and week 24
Blood glucose (mmol/L)
Time frame: Change from baseline to week 12 and week 24
Plasma triglyceride (mmol/L)
Time frame: Change from baseline to week 12 and week 24
Plasma cholesterol (mmol/L)
Time frame: Change from baseline to week 12 and week 24
Plasma High-density lipoprotein (HDL-cholesterol) (mmol/L)
Time frame: Change from baseline to week 12 and week 24
Plasma Low-density lipoprotein (LDL-cholesterol) (mmol/L)
Time frame: Change from baseline to week 12 and week 24
Leptin (µg/L)
Time frame: Change from baseline to week 12 and week 24
Adiponectin (mg/L)
Time frame: Change from baseline to week 12 and week 24
Leptin:Adiponectin ratio
Time frame: Change from baseline to week 12
The five components of the metabolic syndrome: blood glucose, triglyceride, HDL-cholesterol, waist circumference, blood pressure
Time frame: Change from baseline to week 12 and week 24
Insulin (pmol/L)
Time frame: Change from baseline to week 12 and week 24
Homeostasis model assessment for insulin resistance (HOMA-IR)
Time frame: Change from baseline to week 12 and week 24
IGF-I, bioactive IGF and IGF-II (µg/L)
Time frame: Change from baseline to week 12 and week 24
IGFBP 1-3 (µg/L)
Hospitalsenheden Vest
Other
Xbox Kinect Training in Men With Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04000880
Adnexal Diseases, Behavior
Birmingham, Alabama, United States
View Trial DetailsNCT03660085
Behavior, Genital Diseases
Halifax, Nova Scotia, Canada
View Trial DetailsNCT06250751
Behavior, Genital Diseases
Richmond, Virginia, United States
View Trial DetailsNCT05176756
Behavior, Breast Cancer
Duarte, California, United States
View Trial Details